Abstract
At the beginning of 2020, a newly emerged virus, now named SARS-CoV-2, began to spread in China. After four months, it has reached all over the globe, infecting more than 2.5 million people. Currently, there are no proved treatments available. However, in social media, false information about alcohol consumption and its role against the virus is spreading. We described a victim of these false facts, who was present with reduced eyesight due to alcohol drinking. A few days later, he showed symptoms of COVID-19 and, even though received treatment, lost his eyesight partially. Alcohol taking has no preventive or curative effect on COVID-19 and negatively impacts the body and immune system, which, therefore, should not be considered a treatment for COVID-19 disease.
Keywords: COVID-19, SARS-CoV-2, COVID-19 prevention, alcohol, alcohol misuse.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:COVID-19 and Alcohol Misuse: A Case Report
Volume: 21 Issue: 8
Author(s): Ali Asadollahi-Amin, Ali Nowroozi, Mehrdad Hasibi, Behzad Asanjarani and SeyedAhmad SeyedAlinaghi*
Affiliation:
- Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences,0
Keywords: COVID-19, SARS-CoV-2, COVID-19 prevention, alcohol, alcohol misuse.
Abstract: At the beginning of 2020, a newly emerged virus, now named SARS-CoV-2, began to spread in China. After four months, it has reached all over the globe, infecting more than 2.5 million people. Currently, there are no proved treatments available. However, in social media, false information about alcohol consumption and its role against the virus is spreading. We described a victim of these false facts, who was present with reduced eyesight due to alcohol drinking. A few days later, he showed symptoms of COVID-19 and, even though received treatment, lost his eyesight partially. Alcohol taking has no preventive or curative effect on COVID-19 and negatively impacts the body and immune system, which, therefore, should not be considered a treatment for COVID-19 disease.
Export Options
About this article
Cite this article as:
Asadollahi-Amin Ali , Nowroozi Ali , Hasibi Mehrdad , Asanjarani Behzad and SeyedAlinaghi SeyedAhmad *, COVID-19 and Alcohol Misuse: A Case Report, Infectious Disorders - Drug Targets 2021; 21 (8) : e160921191123 . https://dx.doi.org/10.2174/1871526521666210203214533
DOI https://dx.doi.org/10.2174/1871526521666210203214533 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Forecasting of Covid-19 Cases Using Machine Learning Approach
Current Respiratory Medicine Reviews The COVID-19 and Ageism in Social Media
Coronaviruses Recent Patents and Advances on Nanotechnologies against Coronavirus
Recent Patents on Nanotechnology Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation
Combinatorial Chemistry & High Throughput Screening Improving the Stability of Aptamers by Chemical Modification
Current Medicinal Chemistry COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews Impact of COVID-19 Pandemic on Cardiology Resident Training and Education
New Emirates Medical Journal Chemical Biology: Past, Present and Future
Current Chemical Biology Quaternary Structure, Substrate Selectivity and Inhibitor Design for SARS 3C-Like Proteinase
Current Pharmaceutical Design Recent Developments on Coronavirus Main Protease/3C Like Protease Inhibitors
Recent Patents on Anti-Infective Drug Discovery Nanotechnology-based Approaches for COVID-19: A Path Forward
Current Nanomaterials Combination Therapy with Favipiravir for Treatment of Hospitalized COVID-19 Adults
New Emirates Medical Journal High Mutation Rate Leads to Fitness Loss for Coronavirus Quasispecies
Coronaviruses <i>In Silico</i> Identification of New Anti-SARS-CoV-2 Agents from Bioactive Phytocompounds Targeting the Viral Spike Glycoprotein and Human TLR4
Letters in Drug Design & Discovery In Vivo and In Vitro Evaluation of the Therapeutic Potential of Some Turkish Scorzonera Species as Wound Healing Agent
Current Pharmaceutical Design Recent Patents on Cell Cycle Regulatory Proteins
Recent Patents on Biotechnology Characterization of Proteins from Putative Human DNA and RNA Viruses
Current Proteomics Engineering Novel Anticoagulant Proteins by Motif Grafting
Protein & Peptide Letters Neurological Complications in COVID-19 Patients and its Implications for Associated Mortality
Current Neurovascular Research The Genomes of SARS-CoV-2 and Related Coronaviruses: Are Accessory Proteins Key for Pathogenesis?
Coronaviruses